Operating Expenses Summary of Lotus Pharmaceutical Co., Ltd.

Lotus Pharmaceutical Co., Ltd.'s latest annual operating expenses in 2023 was 4.48 Billion TWD , down -7.09% from previous year.
Lotus Pharmaceutical Co., Ltd.'s latest quarterly operating expenses in 2024 Q1 was 1.04 Billion TWD , up 4.24% from previous quarter.
Lotus Pharmaceutical Co., Ltd. reported a annual operating expenses of 3.69 Billion TWD in annual operating expenses 2022, up 11.72% from previous year.
Lotus Pharmaceutical Co., Ltd. reported a annual operating expenses of 3.31 Billion TWD in annual operating expenses 2021, up 10.92% from previous year.
Lotus Pharmaceutical Co., Ltd. reported a quarterly operating expenses of 987.29 Million TWD for 2024 Q2, up 18.78% from previous quarter.
Lotus Pharmaceutical Co., Ltd. reported a quarterly operating expenses of 1 Billion TWD for 2023 Q4, down -14.05% from previous quarter.

Annual Operating Expenses Chart of Lotus Pharmaceutical Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Lotus Pharmaceutical Co., Ltd. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	4.48 Billion TWD	-7.09%
2022	3.69 Billion TWD	11.72%
2021	3.31 Billion TWD	10.92%
2020	2.98 Billion TWD	-4.77%
2019	3.13 Billion TWD	16.48%
2018	2.69 Billion TWD	5.25%
2017	2.55 Billion TWD	-17.09%
2016	3.08 Billion TWD	10.92%
2015	2.77 Billion TWD	74.83%
2014	1.59 Billion TWD	266.06%
2013	434.37 Million TWD	-9.19%
2012	478.34 Million TWD	1.05%
2011	473.36 Million TWD	42.68%
2010	331.76 Million TWD	4.32%
2009	318.02 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	1.04 Billion TWD	4.24%
2024 Q2	987.29 Million TWD	18.78%
2023 Q4	1 Billion TWD	-14.05%
2023 Q2	992.61 Million TWD	-4.81%
2023 Q3	1.17 Billion TWD	17.94%
2023 FY	3.43 Billion TWD	-7.09%
2023 Q1	1.04 Billion TWD	0.13%
2022 FY	3.69 Billion TWD	11.72%
2022 Q3	1.01 Billion TWD	14.0%
2022 Q4	1.04 Billion TWD	2.5%
2022 Q1	749.87 Million TWD	-18.02%
2022 Q2	891.2 Million TWD	18.85%
2021 Q3	778.46 Million TWD	-7.21%
2021 Q4	914.72 Million TWD	17.5%
2021 FY	3.31 Billion TWD	10.92%
2021 Q1	778.27 Million TWD	-12.16%
2021 Q2	838.98 Million TWD	7.8%
2020 Q1	608.7 Million TWD	-34.15%
2020 Q4	885.99 Million TWD	8.99%
2020 Q2	659.36 Million TWD	8.32%
2020 Q3	812.92 Million TWD	23.29%
2020 FY	2.98 Billion TWD	-4.77%
2019 Q2	837.08 Million TWD	32.19%
2019 Q4	924.37 Million TWD	24.99%
2019 FY	3.13 Billion TWD	16.48%
2019 Q1	633.25 Million TWD	-16.57%
2019 Q3	739.54 Million TWD	-11.65%
2018 Q2	682.88 Million TWD	11.17%
2018 FY	2.69 Billion TWD	5.25%
2018 Q4	759.03 Million TWD	19.61%
2018 Q3	634.59 Million TWD	-7.07%
2018 Q1	614.27 Million TWD	-20.09%
2017 Q2	580.06 Million TWD	-2.01%
2017 FY	2.55 Billion TWD	-17.09%
2017 Q4	768.72 Million TWD	24.83%
2017 Q1	591.96 Million TWD	-39.71%
2017 Q3	615.82 Million TWD	6.16%
2016 Q1	631.08 Million TWD	-12.89%
2016 Q4	981.9 Million TWD	34.72%
2016 Q3	728.82 Million TWD	-1.75%
2016 FY	3.08 Billion TWD	10.92%
2016 Q2	741.82 Million TWD	17.55%
2015 FY	2.77 Billion TWD	74.83%
2015 Q3	711.37 Million TWD	6.31%
2015 Q4	724.5 Million TWD	1.85%
2015 Q2	669.14 Million TWD	-0.8%
2015 Q1	674.54 Million TWD	4.98%
2014 Q1	127.46 Million TWD	-16.59%
2014 Q4	642.53 Million TWD	67.77%
2014 Q3	382.99 Million TWD	85.62%
2014 Q2	206.33 Million TWD	61.88%
2014 FY	1.59 Billion TWD	266.06%
2013 Q1	75.77 Million TWD	-46.95%
2013 Q4	152.81 Million TWD	32.95%
2013 Q3	114.93 Million TWD	26.51%
2013 Q2	90.85 Million TWD	19.9%
2013 FY	434.37 Million TWD	-9.19%
2012 FY	478.34 Million TWD	1.05%
2012 Q1	94.07 Million TWD	-31.76%
2012 Q2	147.52 Million TWD	56.82%
2012 Q3	95.44 Million TWD	-35.3%
2012 Q4	142.84 Million TWD	49.65%
2011 Q1	81.2 Million TWD	2.89%
2011 Q2	123.79 Million TWD	52.46%
2011 Q3	130.5 Million TWD	5.42%
2011 Q4	137.85 Million TWD	5.63%
2011 FY	473.36 Million TWD	42.68%
2010 Q3	83.86 Million TWD	-4.56%
2010 Q2	87.86 Million TWD	8.32%
2010 Q1	81.11 Million TWD	0.0%
2010 Q4	78.92 Million TWD	-5.89%
2010 FY	331.76 Million TWD	4.32%
2009 FY	318.02 Million TWD	0.0%

Peer Operating Expenses Comparison of Lotus Pharmaceutical Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Grape King Bio Ltd	6.03 Billion TWD	25.805%
Standard Chem & Pharm CO., LTD.	1.46 Billion TWD	-205.689%
Maywufa Company Ltd.	854.37 Million TWD	-424.464%
ScinoPharm Taiwan, Ltd.	901.49 Million TWD	-397.047%
LIWANLI Innovation Co., Ltd.	54.86 Million TWD	-8066.934%
YungShin Global Holding Corporation	2.04 Billion TWD	-118.825%
PhytoHealth Corporation	67.64 Million TWD	-6524.292%
SCI Pharmtech, Inc.	190.02 Million TWD	-2258.067%
Formosa Laboratories, Inc.	1.24 Billion TWD	-258.942%
PharmaEssentia Corporation	4.49 Billion TWD	0.316%
Bora Pharmaceuticals Co., LTD.	1.74 Billion TWD	-157.211%

Global Stocks Search

Lotus Pharmaceutical Co., Ltd. (1795.TW)

Operating Expenses Summary of Lotus Pharmaceutical Co., Ltd.

Annual Operating Expenses Chart of Lotus Pharmaceutical Co., Ltd. (2023 - 2009)

Historical Annual Operating Expenses of Lotus Pharmaceutical Co., Ltd. (2023 - 2009)

Peer Operating Expenses Comparison of Lotus Pharmaceutical Co., Ltd.